Answers are grounded in this paper and cite their sources.
Multicenter study reveals treatment efficacy and diagnostic delays in juvenile Behçet’s disease, suggesting improved strategies.
Juvenile Behçet's disease in Colombia presents heterogeneous clinical presentations, with a high prevalence of mucocutaneous, musculoskeletal, and neurological involvement. A significant delay in diagnosis was observed, highlighting the need for increased clinical awareness and suspicion. Colchicine and corticosteroids are generally effective, although most patients require immunosuppressive agents, and some require biologic therapy. These findings emphasize the importance of timely diagnosis and individualized treatment strategies to reduce morbidity in affected children.
No takes yet. Share an insight, caveat, or question.
Zabala-Sepúlveda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: